Deals
Theravance Biopharma Secures $50M ATM via Cantor Fitzgerald & Co.
|
Theravance Biopharma (NASDAQ GM:TBPH) announced that it has secured up to $50,000,000 in an ATM (At the Market) transaction.
Growth Capitalist (https://growthcapitalist.com/tag/at-the-market/page/27/)
Theravance Biopharma (NASDAQ GM:TBPH) announced that it has secured up to $50,000,000 in an ATM (At the Market) transaction.
Veracyte (NASDAQ GM:VCYT) announced that it has secured up to $25,000,000 in an ATM (At the Market) transaction with Cantor Fitzgerald & Company.
Bio-Path Holdings (NASDAQ CM:BPTH) announced that it has secured up to $25,000,000 in an ATM (At the Market) transaction.
Real Industry (NASDAQ GS:RELY) announced that it has secured up to $22,389,000 in an ATM (At the Market) transaction.